elobixibat
Selected indexed studies
- Comparative profiles of lubiprostone, linaclotide, and elobixibat for chronic constipation: a systematic literature review with meta-analysis and number needed to treat/harm. (BMC Gastroenterol, 2024) [PMID:38166671]
- Elobixibat for the treatment of constipation. (Expert Opin Investig Drugs, 2013) [PMID:23215781]
- Review article: Elobixibat: a novel treatment for chronic constipation. (Aliment Pharmacol Ther, 2021) [PMID:33296518]
_Worker-drafted node — pending editorial review._
Connections
elobixibat is a side effect of
Sources
- Comparative profiles of lubiprostone, linaclotide, and elobixibat for chronic constipation: a systematic literature review with meta-analysis and number needed to treat/harm. (2024) pubmed
- Elobixibat for the treatment of constipation. (2013) pubmed
- Review article: Elobixibat: a novel treatment for chronic constipation. (2021) pubmed
- Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD Study. (2024) pubmed
- Elobixibat and its potential role in chronic idiopathic constipation. (2014) pubmed
- Elobixibat for the treatment of constipation. (2018) pubmed
- Efficacy of elobixibat for elderly patients with chronic constipation in a clinic. (2025) pubmed
- Usefulness of Elobixibat in Patients With Chronic Constipation After Cholecystectomy. (2024) pubmed
- Elobixibat Improves Stool/Gas Distribution and Fecal Bile Acids in Older Adults With Chronic Constipation. (2025) pubmed
- Elobixibat improves rectal sensation in patients with chronic constipation aged ≥60 years: a randomised placebo-controlled study. (2023) pubmed